Delayed clinical improvement is frequently dismissed as placebo, regression to the mean, or nonspecific fluctuation. This interpretation assumes that effective treatment should produce early and clearly attributable responses. This paper challenges that assumption by reframing delayed response as a physiologically plausible outcome in dynamically regulated systems. In the context discussed here, the patient receives active treatment and pharmacological exposure is adequate, but the clinical response emerges only after a delay. Such latency reflects system inertia, regulatory reorganization, and timing sensitivity rather than lack of efficacy. Delayed response therefore represents meaningful diagnostic information rather than weak or nonspecific change. Misclassifying delayed improvement as placebo can lead to premature discontinuation, unnecessary escalation, and misinterpretation of treatment failure. This work presents a clinical interpretation framework within Dynamic Medicine, emphasizing response timing and system behavior over early endpoints. No new experimental or clinical data are introduced.